Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial

Clinical trial NCT03082846 · COMPLETED

Trial details

NCT number: NCT03082846
Sponsor: Xue Xiaoying
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Glioma Radiotherapy, Intensity-Modulated Maximum Tolerated Dose

Start date: 2014-01-01
Primary completion: 2016-11-07
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.